These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Facility for small volume parenteral manufacturing. Kelly PC Bull Parenter Drug Assoc; 1976; 30(2):72-9. PubMed ID: 949564 [No Abstract] [Full Text] [Related]
34. Drug incompatibility from the standpoint of the intravenous route of drug administration. Williams JT Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868 [No Abstract] [Full Text] [Related]
35. [Problems with infusion mixtures in health departments]. Malý J; Samková M Zdrav Prac; 1975 Oct; 25(10):597-600. PubMed ID: 1045763 [No Abstract] [Full Text] [Related]
36. I. V. additive program belongs in the pharmacy. Brown RG Hospitals; 1969 Sep; 43(18):92-8. PubMed ID: 5809375 [No Abstract] [Full Text] [Related]
37. Recommendations to pharmacists for solving problems with large-volume parenterals-1979. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1980 May; 37(5):663-7. PubMed ID: 7386474 [No Abstract] [Full Text] [Related]
38. Aspects of current parenteral formulation. Scheindlin S Bull Parenter Drug Assoc; 1970; 24(1):31-9. PubMed ID: 5415610 [No Abstract] [Full Text] [Related]
39. [Quality control of infusion solutions. I. Foreign particles in infusion solutions]. van den Bemd AA Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140 [No Abstract] [Full Text] [Related]
40. Stability of dobutamine hydrochloride in selected large-volume parenterals. Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]